Biomarkers for Carcinoma Meningitis in Solid Tumors
نویسندگان
چکیده
منابع مشابه
Carcinomatous meningitis: Leptomeningeal metastases in solid tumors
Leptomeningeal metastasis (LM) results from metastatic spread of cancer to the leptomeninges, giving rise to central nervous system dysfunction. Breast cancer, lung cancer, and melanoma are the most frequent causes of LM among solid tumors in adults. An early diagnosis of LM, before fixed neurologic deficits are manifest, permits earlier and potentially more effective treatment, thus leading to...
متن کاملNeoplastic meningitis in solid tumors: from diagnosis to personalized treatments
Neoplastic meningitis (NM) is a devastating complication of solid tumors with poor outcome. Some randomized clinical trials have been conducted with heterogeneous inclusion criteria, diagnostic parameters, response evaluation and primary endpoints. Recently, the Leptomeningeal Assessment in Neuro-Oncology (LANO) Group and the European Society for Medical Oncology/European Association for Neuro-...
متن کاملBiomarkers predictive of GSI response in solid tumors
Merck Research Laboratory, Boston MA 02115. Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115. Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadephia, PA 19104. Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, MA 02114. Department of Medicine and Digestive Health R...
متن کاملBevacizumab for renal cell carcinoma, glioblastoma, and other solid tumors.
Indications Renal cell carcinoma In July 2009, the US Food and Drug Administration (FDA) granted approval for use of the vascular endothelial growth factor (VEGF) inhibitor bevacizumab (Avastin) in combination with interferon alfa for treatment of patients with metastatic renal cell carcinoma (RCC). Approval was based on results from the BO17705 trial, which demonstrated a 5-month improvement i...
متن کاملDatabase of genomic biomarkers for cancer drugs and clinical targetability in solid tumors.
SUMMARY Comprehensive genomic profiling is expected to revolutionize cancer therapy. In this Prospective, we present the prevalence of mutations and copy-number alterations with predictive associations across solid tumors at different levels of stringency for gene-drug targetability. More than 90% of The Cancer Genome Atlas samples have potentially targetable alterations, the majority with mult...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Advances in Medicine and Medical Research
سال: 2018
ISSN: 2456-8899
DOI: 10.9734/jammr/2018/41792